Diabetes Focus |
|
Step inside to see earlier, quantitative,
detection of diabetic neuropathy
|
For over a decade, NeuroMetrix has been dedicated to delivering innovative products that are useful in the evaluation, diagnosis and management of nerve disorders such as diabetic peripheral
neuropathy (DPN). We are committed to improving the standard
of care for people with diabetes.
DPN is a nerve disorder that affects 60-70% of patients with diabetes.
DPN can drastically impact a patient’s health and quality of life, but if detected early and with proper clinical intervention, more positive outcomes are possible.
NeuroMetrix’s latest product called NC-stat® | DPNCheck™
– has the potential to revolutionize the management of DPN by
providing physicians with quantitative nerve conduction data at
the point-of-care. The device is a modified version of the widely
used NC-stat® System.
To learn more, click here
NeuroMetrix Diabetic Neuropathy Scientific Advisory Board:
- David G. Armstrong, MD, PhD
- Andrew J.M. Boulton, MRCP (UK), MD, FRCP
- Neil H. Brooks, MD, FAAFP
- Bruce A. Perkins, MD, MPH, FRCP(C)
- Solomon Tesfaye, MB ChB, MD, FRCP (UK)
- Aaron I. Vinik, MD, PhD, FCP, FACP
- Dan Ziegler, MD, FRCPE
|
|